Complex visual hallucinations in a patient with chronic schizophrenia and alcohol dependence: a case report and literature review

References

1. David CN, Greenstein D, Classen L, Gocham P, Miller R, Tossell JW, et al. Childhood onset schizophrenia: high rate of visual hallucinations. J Am Acad Child Adolesc Psychiatry 2011;50:681–6.10.1016/j.jaac.2011.03.020Search in Google Scholar

2. Bracha HS, Wolkowitz OM, Lohr JB, Karson CN, Bigelow LB. High prevalence of visual hallucinations in research subjects with chronic schizophrenia. Am J Psychiatry 1989;146:526–8.10.1176/ajp.146.4.526Search in Google Scholar

3. Zarroug ET. The frequency of visual hallucinations in schizophrenic patients in Saudi Arabia. Br J Psychiatry 1975;127:553–5.10.1192/bjp.127.6.553Search in Google Scholar

4. Ndetei DM, Singh A. Hallucinations in Kenyan schizophrenic patients. Acta Psychiatr Scand 1983;67:144–7.10.1111/j.1600-0447.1983.tb00334.xSearch in Google Scholar

5. Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain 1998;121:1819–40.10.1093/brain/121.10.1819Search in Google Scholar

6. Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacol 1995;13:9–19.10.1016/0893-133X(94)00131-ISearch in Google Scholar

7. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995;378:176–9.10.1038/378176a0Search in Google Scholar PubMed

8. Mueser KT, Bellack AS, Brady EU. Hallucinations in schizophrenia. Acta Psychiatr Scand 1990;82:26–9.10.1111/j.1600-0447.1990.tb01350.xSearch in Google Scholar PubMed

9. Platz WE, Oberlaender FA, Seidel ML. The phenomenology of perceptual hallucinations in alcohol-induced delirium tremens. Psychopathology 1995;28:247–55.10.1159/000284935Search in Google Scholar PubMed

10. Muzyk AJ, Fowler JA, Norwood DK, Chilipko A. Role of a2–agonists in the treatment of acute alcohol withdrawal. Ann Pharmacother 2011;45:649–57.10.1345/aph.1P575Search in Google Scholar PubMed

11. Monahan J, Steadman HJ. Violence and mental Disorder: Developments in risk assessment. Chicago, IL: University Chicago Press, 1994.Search in Google Scholar

12. Hemmingsen RM, Kramp P. Delirium tremens and related clinical states: psychopathology, cerebral pathophysiology and psychochemistry: a two-component hypothesis concerning etiology and pathogenesis. Acta Psychiatr Scand 1988;78(S345):94–107.10.1111/j.1600-0447.1988.tb08575.xSearch in Google Scholar

13. Hemmingse R, Vorstrup SC, Holm S. Cerebral blood flow during delirium tremens and related clinical states studied with xenon-133 inhalation tomography. Am J Psychiatry 1988;145:1384–90.10.1176/ajp.145.11.1384Search in Google Scholar PubMed

14. Salo R, Flower K, Kielstein A, Leamon MH, Nordahl TE, Galloway GP. Psychiatric comorbidity in methamphetamine dependence. Psychiatry Res 2011;186:356–61.10.1016/j.psychres.2010.09.014Search in Google Scholar PubMed PubMed Central

15. Sato M, Numachi Y, Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 1992;18:115–22.10.1093/schbul/18.1.115Search in Google Scholar PubMed

16. Núñez LA, Gurpegui M. Cannabis-induced psychosis: a cross-sectional comparison with acute schizophrenia. Acta Psychiatr Scand 2002;105:173–8.10.1034/j.1600-0447.2002.1o079.xSearch in Google Scholar PubMed

17. Pelak VS, Liu GT. Visual hallucinations. Curr Treat Options Neurol 2004;6:75–83.10.1007/s11940-004-0041-4Search in Google Scholar PubMed

18. Hirschhorn ID, Winter JC. Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli. Psychopharmacology 1971;22:64–71.10.1007/BF00401468Search in Google Scholar PubMed

19. Herman CB, Merlis D, Merlis S. Studies of mescaline I. Action in schizophrenic patients. Psychiatr Q 1955;29:421–9.Search in Google Scholar

20. Abraham HD, Aldrige AM. Adverse consequences of lysergic acid diethylamide. Addiction 1993;88:1327–34.10.1111/j.1360-0443.1993.tb02018.xSearch in Google Scholar PubMed

21. Deshon HJ, Rinkel M, Solomon HC. Mental changes experimentally produced by d–lysergic acid diethylamide tartrate. Psychiatr Q 1952;26:33–53.10.1007/BF01568448Search in Google Scholar PubMed

22. Kuramochi H, Takahashi R. Psychopathology of LSD intoxication study of experimental psychosis induced by LSD-25: description of LSD symptoms in normal oriental subjects. Arch Gen Psychiatry 1964;11:151–61.10.1001/archpsyc.1964.01720260045006Search in Google Scholar PubMed

23. Aghajaniana GK, Haiglera HJ, Bloom FE. Lysergic acid diethylamide and serotonin: direct actions on serotonin-containing neurons in rat brain. Life Sci 1972;11:615–22.10.1016/0024-3205(72)90153-1Search in Google Scholar

24. White FJ, Appel JB. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological action. Science 1982;216:535–7.10.1126/science.7071600Search in Google Scholar PubMed

25. Winstock AR. What should be done about mephedrone? Br Med J 2010;340:c1605.10.1136/bmj.c1605Search in Google Scholar PubMed

26. Prosser JM, Nelso SL. The toxicity of bath salts: A review of synthetic cathinones. J Med Toxicol 2012;8:33–42.10.1007/s13181-011-0193-zSearch in Google Scholar PubMed PubMed Central

27. Drug Enforcement Administration News Release, October 21, 2011. http://www.justice.gov/dea/pubs/pressrel/pr102111.html. Accessed February 1, 2012.Search in Google Scholar

28. Bajaj N, Mullen D, Wylie S. Dependence and psychosis with 4-methylmethcathinone (mephedrone) use. BMJ Case Reports 2010; doi:10.1136/bcr.02.2010.2780.10.1136/bcr.02.2010.2780Search in Google Scholar PubMed PubMed Central

29. Wood DM, Davies S, Puchnarewicz M, Button J, Archer R, Ovaska H, et al. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 2010;6:327–30.10.1007/s13181-010-0018-5Search in Google Scholar PubMed PubMed Central

30. Wood DM, Greene SL, Dargan PI. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J 2011;28:280–2.10.1136/emj.2010.092288Search in Google Scholar PubMed

31. Vignal1 JP, Maillard L, McGonigal A, Chauvel P. The dreamy state: hallucinations of autobiographic memory evoked by temporal lobe stimulations and seizures. Brain 2007;130:88–99.10.1093/brain/awl329Search in Google Scholar PubMed

32. Bien CG, Benninger FO, Urbach H, Schramm J, Kurthen M, Elger CE. Localizing value of epileptic visual auras. Brain 2000;123:244–53.10.1093/brain/123.2.244Search in Google Scholar PubMed

33. Sowa MV, Pituck S. Prolonged spontaneous complex visual hallucinations and illusions as ictal phenomena. Epilepsia 1989;30:524–6.10.1111/j.1528-1157.1989.tb05466.xSearch in Google Scholar PubMed

34. Burghaus L, Eggers C, Timmermann L, Fink GR, Diederich NJ. Hallucinations in neurodegenerative diseases. CNS Neurosci Ther 2012;18:149–59.10.1111/j.1755-5949.2011.00247.xSearch in Google Scholar PubMed PubMed Central

35. Ferro JM, Caeiro L, Verdelho A. Delirium in acute stroke. Curr Opin Neurol 2002;15:51–5.10.1097/00019052-200202000-00009Search in Google Scholar PubMed

36. Beckson M, Cummings JL. Neuropsychiatric aspects of stroke. Int J Psychiatry Med 1991;21:1–15.10.2190/EUMY-3MGP-MWB2-CWG9Search in Google Scholar PubMed

37. Beniczky S, Kéri S, Vörös E, Ungureán A, Benedek G, Janka Z, et al. Complex hallucinations following occipital lobe damage. Eur J Neurol 2002;9:175–6.10.1046/j.1468-1331.2002.00353.xSearch in Google Scholar PubMed

38. Mocellin R, Walterfang M, Velakoulis D. Neuropsychiatry of complex visual hallucinations. Aust NZ J Psychiatr 2006;40:742–51.10.1080/j.1440-1614.2006.01878.xSearch in Google Scholar PubMed

39. Noda S, Mizoguchi M, Yamamoto A. Thalamic experiential hallucinosis. J Neurol Neurosurg Psychiatry 1993;56:1224–6.10.1136/jnnp.56.11.1224Search in Google Scholar PubMed PubMed Central

40. Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002;125:391–403.10.1093/brain/awf033Search in Google Scholar PubMed

41. Mega MS, Lee L, Dinov ID, Mishkin F, Toga AW, Cummings JL. Cerebral correlates of psychotic symptoms in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2000;69:167–71.10.1136/jnnp.69.2.167Search in Google Scholar PubMed PubMed Central

42. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol 1996;53:1265–8.10.1001/archneur.1996.00550120077019Search in Google Scholar PubMed

43. Diederich NJ, Alesch F, Goetz CG. Visual hallucinations induced by deep brain stimulation in Parkinson’s disease. Clin Neuropharmacol 2000;23:287–9.10.1097/00002826-200009000-00010Search in Google Scholar PubMed

44. Shine JM, Halliday GM, Naismith SL, Lewis SJ. Visual misperceptions and hallucinations in Parkinson’s disease: dysfunction of attentional control networks? Mov Disord 2011;26:2154–9.10.1002/mds.23896Search in Google Scholar

45. Holroyd S, Shepherd ML, Downs JH. Occipital atrophy is associated with visual hallucinations in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 2000;12:25–8.10.1176/jnp.12.1.25Search in Google Scholar

46. Sultzer DL, Mahler ME, Mandelkern MA, Cummings JL, Van Gorp WG, Hinkin CH, et al. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer’s disease. J Neuropsychiatry Clin Neurosci 1995;7:476–84.10.1176/jnp.7.4.476Search in Google Scholar

47. Alfred L, Karlheinz R, Klaus VT. Meningeal hyperperfusion visualized by MRI in a patient with visual hallucinations and migraine. Headache 1996;36:53–7.10.1046/j.1526-4610.1996.3601053.xSearch in Google Scholar

48. Menon GJ, Rahman I, Menon SJ, Dutton GN. Complex visual hallucinations in the visually impaired: the Charles Bonnet syndrome. Surv Opthalmol 2003;48:58–72.10.1016/S0039-6257(02)00414-9Search in Google Scholar

49. Benaur M, Kahn D. Clinical case discussion commentary on visual hallucinations and Charles Bonnet syndrome case discussion. J Psychiatr Pract 2011;17:142–4.10.1097/01.pra.0000396068.64472.eeSearch in Google Scholar

50. Santhouse AM, Howard RJ, Fytche DH. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain 2000;123: 2055–64.10.1093/brain/123.10.2055Search in Google Scholar

51. Teunisse RJ, Zitman FG, Cruysberg JR, Hoefnagels WH, Verbeek AL. Visual hallucinations in psychologically normal people: Charles Bonnet’s syndrome. Lancet 1996;347: 794–7.10.1016/S0140-6736(96)90869-7Search in Google Scholar

52. Jang JW, Youn YC, Seok JW, Ha SY, Shin HW, Ahan SW, et al. Hypermetabolism in the left thalamus and right inferior temporal area on positron emission tomography–statistical parametric mapping (PET–SPM) in a patient with Charles Bonnet syndrome resolving after treatment with valproic acid. J Clin Neurosci 2011;18:1130–2.10.1016/j.jocn.2010.12.038Search in Google Scholar PubMed

53. Tallaksen CM, Kerty E, Bakke S. Visual hallucinations in a case of reversible hypertension-induced brain oedema. Eur J Neurol 1998;5:615–8.10.1046/j.1468-1331.1998.560615.xSearch in Google Scholar PubMed

54. Romanos M. Migrainous complex hallucinations in 10-year old patient – a case report and review. Z Kinder Jugend Psychiatr Psychother 2004;32:201–7.Search in Google Scholar

55. Lindner A, Reiners K, Toyka KV. Meningeal hyperperfusion visualized by MRI in a patient with visual hallucinations and migraine. Headache 1996;36:53–7.10.1046/j.1526-4610.1996.3601053.xSearch in Google Scholar

56. Cohen MA, Alfonso CA, Haque MM. Lilliputian hallucinations and medical illness. Gen Hosp Psychiatry 1994;16:141–3.10.1016/0163-8343(94)90060-4Search in Google Scholar

57. Mott RH, Small IF, Anderson JM. Comparative study of hallucinations. Arch Gen Psychiatry 1965;12:595–601.10.1001/archpsyc.1965.01720360067011Search in Google Scholar PubMed

58. Alvaro LC. Hallucinations and pathological visual perceptions in Maupassant’s fantastical short stories–a neurological approach. J Hist Neurosci 2005;14:100–15.10.1080/096470490523399Search in Google Scholar PubMed